Evidence map›Paper›PMID 39937142›Full record

ReviewMicrobial biotechnology2025

Harnessing Bacteriophages for Sustainable Crop Protection in the Face of Climate Change.

Robert Czajkowski, Amalia Roca, Miguel A Matilla

Abstract readReview
In one paragraph

Review in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Novel LyticViruses · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Rethinking microbial biopesticide development and uptake.World journal of microbiology & biotechnology · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert CzajkowskiLaboratory of Biologically Active Compounds, Intercollegiate Faculty of Biotechnology UG and MUG, University of Gdansk, Gdansk, Poland.ORCID https://orcid.org/0000-0001-9641-5603
Amalia RocaDepartment of Microbiology, Facultad de Farmacia, Campus Universitario de Cartuja, Universidad de Granada, Granada, Spain.ORCID https://orcid.org/0000-0003-2332-3112
Miguel A MatillaDepartment of Biotechnology and Environmental Protection, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Granada, Spain.ORCID https://orcid.org/0000-0002-8468-9604

Funding

Polish National Science Center 2020/38/E/NZ9/00007Spanish Ministry for Science and Innovation RYC2019-026481-ISpanish Ministry for Science, Innovation and Universities PID2023-146281NB-I00
6 · The paper itself

Abstract

Crop pathogens represent a major challenge to global food security, causing over 40% yield losses in key crops and annual economic impacts estimated at up to US$290 billion. Microbial-based alternatives to synthetic agrochemicals offer sustainable solutions aligned with global initiatives like the European Union's Green Deal. Among these, bacteriophage (phage) therapy has gained attention for its specificity, effectiveness against plant pathogens and safety for crops. Here, we highlight recent research on phage therapy strategies and their potential utility in sustainable agriculture, showcasing its effectiveness in reducing phytopathogen densities, delaying plant disease onset, and enriching plant-associated bacterial taxa with biocontrol potential. Phage cocktails improve biocontrol, mitigate resistance, and synergize with other biological and chemical agents. Emerging technologies like engineered phages also promise enhanced efficacy. Addressing challenges like phytopathogen resistance, field inconsistencies, and regulatory hurdles is crucial to integrating phage therapy into sustainable agriculture under climate stress.

Indexed as

BacteriophagesClimate ChangeCrop ProtectionCrops, AgriculturalPlant DiseasesAgricultureBiological Control AgentsPhage TherapyBiological Control Agents

Identifiers

PMID39937142
PMCPMC11816701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.